Achieving sustainability, quality and access

lessons from the world's largest revolving drug fund in Khartoum

Sophie Witter

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Ensuring a reliable and affordable supply of essential drugs to health facilities is one of the main challenges facing developing countries. This paper describes the revolving drug fund in Khartoum, which was set up in 1989 to improve access to high quality drugs across the State. An evaluation in 2004 showed that the fund has successfully managed a number of threats to its financial sustainability and has expanded its network of facilities, its range of products and its financial assets. It now supplies essential drugs to 3 million out of the 5 million population of Khartoum each year, at prices between 40% and 100% less than alternative sources. However, results illustrated the tension between achieving an efficient cost-recovery system and access for the poorest.
Original languageEnglish
Pages (from-to)1476-1485
Number of pages10
JournalEastern Mediterranean Health Journal
Volume13
Issue number6
Publication statusPublished - 2007

Fingerprint

Essential Drugs
Financial Management
Health Facilities
Pharmaceutical Preparations
Developing Countries
Costs and Cost Analysis
Population
Financial Statements

Cite this

Achieving sustainability, quality and access : lessons from the world's largest revolving drug fund in Khartoum. / Witter, Sophie.

In: Eastern Mediterranean Health Journal, Vol. 13, No. 6, 2007, p. 1476-1485.

Research output: Contribution to journalArticle

@article{834a8877262a42dc8a6deec6c0535ec8,
title = "Achieving sustainability, quality and access: lessons from the world's largest revolving drug fund in Khartoum",
abstract = "Ensuring a reliable and affordable supply of essential drugs to health facilities is one of the main challenges facing developing countries. This paper describes the revolving drug fund in Khartoum, which was set up in 1989 to improve access to high quality drugs across the State. An evaluation in 2004 showed that the fund has successfully managed a number of threats to its financial sustainability and has expanded its network of facilities, its range of products and its financial assets. It now supplies essential drugs to 3 million out of the 5 million population of Khartoum each year, at prices between 40{\%} and 100{\%} less than alternative sources. However, results illustrated the tension between achieving an efficient cost-recovery system and access for the poorest.",
author = "Sophie Witter",
year = "2007",
language = "English",
volume = "13",
pages = "1476--1485",
journal = "Eastern Mediterranean Health Journal",
issn = "1020-3397",
publisher = "World Health Organization",
number = "6",

}

TY - JOUR

T1 - Achieving sustainability, quality and access

T2 - lessons from the world's largest revolving drug fund in Khartoum

AU - Witter, Sophie

PY - 2007

Y1 - 2007

N2 - Ensuring a reliable and affordable supply of essential drugs to health facilities is one of the main challenges facing developing countries. This paper describes the revolving drug fund in Khartoum, which was set up in 1989 to improve access to high quality drugs across the State. An evaluation in 2004 showed that the fund has successfully managed a number of threats to its financial sustainability and has expanded its network of facilities, its range of products and its financial assets. It now supplies essential drugs to 3 million out of the 5 million population of Khartoum each year, at prices between 40% and 100% less than alternative sources. However, results illustrated the tension between achieving an efficient cost-recovery system and access for the poorest.

AB - Ensuring a reliable and affordable supply of essential drugs to health facilities is one of the main challenges facing developing countries. This paper describes the revolving drug fund in Khartoum, which was set up in 1989 to improve access to high quality drugs across the State. An evaluation in 2004 showed that the fund has successfully managed a number of threats to its financial sustainability and has expanded its network of facilities, its range of products and its financial assets. It now supplies essential drugs to 3 million out of the 5 million population of Khartoum each year, at prices between 40% and 100% less than alternative sources. However, results illustrated the tension between achieving an efficient cost-recovery system and access for the poorest.

M3 - Article

VL - 13

SP - 1476

EP - 1485

JO - Eastern Mediterranean Health Journal

JF - Eastern Mediterranean Health Journal

SN - 1020-3397

IS - 6

ER -